Work

Cilengitide: An RGD Pentapeptide ανβ3 and ανβ5 Integrin Inhibitor in Development for Glioblastoma and Other Malignancies

Year: 2011

Type: article

Source: Future Oncology

DOI: 10.2217/fon.11.8

Authors: David A Reardon, Bart Neyns, Michael Weller, Joerg Christian Tonn, Louis Burt Nabors, Roger Stupp

Institutions: Duke University, Duke Medical Center, Universitair Ziekenhuis Brussel, University Hospital Zurich, LMU Klinikum, Ludwig-Maximilians-Universität München, University of Alabama at Birmingham, Centre Hospitalier Universitaire Vaudois

Language: English

Topic: Cell Adhesion Molecules Research

Subfield: Immunology and Allergy

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2103816610

FWCI: 8.954

Cites: 105

Cited by: 110

Related to: 10